Zimmer Biomet Holdings Inc(ZBH) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 23 at 5:26 PM ET (Korea 10/24 06:26)
Full metrics table
| Index | S&P 500 | P/E | 23.99 | EPS (ttm) | 4.11 | Insider Own | 0.18% | Shs Outstand | 190.6M | Perf Week | 3.77% |
| Market Cap | 18.80B | Forward P/E | 10.88 | EPS next Y | 6.13% | Insider Trans | -3.83% | Shs Float | 190.4M | Perf Month | 9.89% |
| Enterprise Value | 25.88B | PEG | 1.88 | EPS next Q | 1.88 | Inst Own | 106.67% | Short Float | 5.12% | Perf Quarter | 7.05% |
| Income | 0.81B | P/S | 2.21 | EPS this Y | 4.11% | Inst Trans | 1.88% | Short Ratio | 4.67 | Perf Half Y | 8% |
| Sales | 8.51B | P/B | 1.49 | EPS next 5Y | 5.79% | ROA | 3.53% | Short Interest | 9.75M | Perf YTD | 9.61% |
| Book/sh | 66.23 | P/C | 45.85 | EPS past 3/5Y | 47.75% - | ROE | 6.42% | 52W High | -5.37% ($104.15) | Perf Year | -4.46% |
| Cash/sh | 2.15 | P/FCF | 15.66 | Sales past 3/5Y | 5.85% 3.22% | ROIC | 4.27% | 52W Low | 24.57% ($79.12) | Perf 3Y | -6.28% |
| Dividend Est. | $1.04 (1.05%) | EV/EBITDA | 10.36 | EPS Y/Y TTM | 0.09% | Gross Margin | 61.43% | Volatility(W/M) | 2.55% 2.37% | Perf 5Y | -32.46% |
| Dividend TTM | 0.96 | EV/Sales | 3.04 | Sales Y/Y TTM | 8.62% | Oper. Margin | 16.33% | ATR (14) | 2.48 | Perf 10Y | -20.33% |
| Dividend Ex-Date | 2026/9/30 | Quick Ratio | 0.94 | EPS Q/Q | 33.47% | Profit Margin | 9.48% | RSI (14) | 63.92 | Recom | 2.53 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.69 | Sales Q/Q | 4.8% | SMA20 | 6.87% ($92.22) | Beta | 0.51 | Target Price | $105.75 |
| Payout | 27.05% | Debt/Eq | 0.59 | Earnings | 2026/11/4 | SMA50 | 3.57% ($95.16) | Rel Volume | 0.97 | Prev Close | $98.81 |
| Employees | 17000 | LT Debt/Eq | 0.5 | EPS/Sales Surpr. | 2.97% 1.97% | SMA200 | 7.71% ($91.5) | Avg Volume(3M) | 2.09M | Price | $98.56 |
| IPO | 2001/7/25 | Option/Short | Yes/Yes | Trades | 17522 | Volume | 2,016,773 | Change | -0.25% |
🦴 A global medical device company that manufactures orthopedic medical devices. It supplies knee and hip artificial joints, as well as trauma, spine, and sports medicine products, along with surgical robots and software, and is driven by demand for joint replacement surgeries amid population aging. It is one of the leading companies in the orthopedic medical device sector.
Over the past 1 year, on the higher side
5% below its 1-year high.
Traded about as much as usual. That is 97% of its average volume.
Next earnings report: November 4
9 days to go.
ZBH earns at a steady pace
Of every $100 in sales, $16.33 is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by +4.1% this year.
Tap to view numbers
Within its industry, it looks cheap
Counting its debt, for $100 of yearly operating cash you would pay $1,036. Peers typically go for $1,594. It is about in line with its own 5-year average.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -32.5%. The S&P 500 did +68% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 1.05% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 106.7%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #10 of 143 in the industry
Based on market cap of $19B.
PHG#8 Koninklijke Philips NV ADR $26B PER 20.0 
STE#9 Steris Plc $23B PER 28.4 ZBH#10 Zimmer Biomet Holdings Inc $19B PER 24.0 
SNN#11 Smith & Nephew plc ADR $13B PER 21.0 
PEN#12 Penumbra Inc $13B PER 79.7 
FAQ
What kind of company is ZBH?
ZBH belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of ZBH?
The market cap of ZBH is approximately $18.8B, ranking 625 within its sector.
Does ZBH pay dividends?
ZBH has a dividend yield of approximately 1.05%, with an annual dividend of $1.04.
What is the P/E ratio of ZBH?
ZBH has a P/E ratio of approximately 24.0x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for ZBH?
ZBH has recorded a 52-week high of $104.15 and a low of $79.12.
